Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
Inflamm Bowel Dis
.
2022 Jan 5;28(1):150.
doi: 10.1093/ibd/izab242.
Authors
Fernando Bermejo
1
,
Laura Jiménez
1
,
Alicia Algaba
1
,
Milagros Vela
2
,
Guillermo Bastida
3
,
Olga Merino
4
,
Alicia López-García
5
,
Luigi Melcarne
6
,
Iago Rodríguez-Lago
7
,
Saioa de la Maza
8
,
Abdel Bouhmidi
9
,
Manuel Barreiro-de Acosta
10
,
Pilar López-Serrano
11
,
Marta Carrillo-Palau
12
,
Francisco Mesonero
13
,
Beatriz Orts
14
,
Daniel Bonillo
1
,
Alicia Granja
1
,
Iván Guerra
1
Affiliations
1
Hospital Universitario de Fuenlabrada, Instituto de Investigación Sanitaria del Hospital La Paz (IdiPaz), Madrid, Spain.
2
Complejo Hospitalario Universitario Ntra. Sra. de Candelaria, Santa Cruz de Tenerife, Tenerife, Spain.
3
Hospital Universitario y Politécnico La Fe, CIBEREHD, Health Research Institute La Fe, Valencia, Spain.
4
Hospital Universitario de Cruces, Vizcaya, Spain.
5
Hospital del Mar and Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
6
Hospital Universitari Parc Taulí, Sabadell, Spain.
7
Hospital Galdakao-Usansolo and Biocruces Bizkaia Health Research Institute, Galdakao, Vizcaya, Spain.
8
Hospital Universitario Basurto, Bilbao, Vizcaya, Spain.
9
Hospital de Santa Bárbara, Puertollano, Cuidad Real, Spain.
10
Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
11
Hospital Universitario Fundación Alcorcón, Madrid, Spain.
12
Hospital Universitario de Canarias, Tenerife, Spain.
13
Hospital Universitario Ramón y Cajal, Madrid, Spain.
14
Hospital General Universitario de Alicante, Alicante, Spain.
PMID:
34636902
DOI:
10.1093/ibd/izab242
No abstract available
Publication types
Published Erratum